A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
Health Tech
4 graded Health Tech names, ranked by quality grade. Each grade is a research-triage signal from end-of-day fundamentals — not a buy/sell call.
| Company | Grade | Rev growth | Rule of 40 |
|---|---|---|---|
| Veeva Systems Inc. VEEV | Strong | 16.2% | 45 |
| CRISPR Therapeutics AG CRSP | Caution (early) | — | -4035.7 |
| Intellia Therapeutics, Inc. NTLA | Caution (early) | 12.6% | -699.1 |
| Tempus AI, Inc. TEM | Promising (early) | 50.4% | 30.6 |
Open the interactive screener → · See whether the grades worked →
Data as of 2026-08-21 08:12 (end-of-day). How grades are computed →